1 Day
Source:
وكالة الانباء الاردنية
Russia vets wider use of Oncorena for colon cancer
The Russian Biological Medicine Agency announced that Moscow has begun expanding the use of the "OncoRNA" vaccine to treat patients with early-stage colon and rectal cancer, following its clinical approval in April. The vaccine is now being more widely used across the country to boost its effectiveness in treating patients who display unstable indicators in tumor genes.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)